Hosted on MSN6d
FDA grants ODD status to Zai Lab’s lung cancer treatment
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).
Investing6d
Zai Lab Ltd (ZLAB)
Zai Lab Limited Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 Zai Lab (NASDAQ:ZLAB) Limited (ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA ...
Yahoo Finance3d
Zai Lab Limited (ZLAB)
January 23, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ZL-1310, a potential highly ...
gadgets3604d
Sony Xperia ZL
Sony Xperia ZL mobile was launched in March 2013. The phone comes with a 5.00-inch touchscreen display offering a resolution of 1080x1920 pixels at a pixel density of 441 pixels per inch (ppi). Sony ...
Yahoo Finance6d
Zai Lab Limited (9688.HK)
2359.HK WuXi AppTec Co., Ltd.
Yahoo Finance6d
Zai Lab Limited (ZLAB)
After hours: 24 January at 7:10:52 pm GMT-5 ...